Company Financials

BB Biotech AG Financials

Swiss franc

business BB Biotech AG Company Profile

Main Stock Listing

SIX: BION

Market Capitalization CHF1.67 Billion as of July 1, 2025

Market Cap History

Valuations Metrics as of Jan. 3, 2026

Trailing PE 14.88
Forward PE 9.15
Price to Sales TTM CHF12.31
Price to Book MRQ CHF1.07
Enterprise to Revenue 12.02
Enterprise to EBITDA

Financial Reports as of Jun. 30, 2025

Financials

Fiscal Year Ends 2024-12-31
Most Recent Quarter 2025-06-30
Profit Margin 82.47%
Operating Margin 98.53%
Return on Assets TTM 4.53%
Return on Equity TTM 7.32%

Income Statement

Revenue TTM CHF201,412,992
Revenue per Share TTM CHF3.68
Quarterly Revenue Growth -60.79%
Gross Profit TTM CHF201,412,992
EBITDA CHF0
Net Income to Common TTM CHF166,104,000
Diluted EPS TTM CHF3.02
Quarterly Earnings Growth YoY 18.12%

Balance Sheet

Total Cash MRQ CHF81,938,000
Total Cash per Share MRQ CHF1.49
Total Debt MRQ CHF
Total Debt to Equity MRQ 0.00
Current Ratio MRQ 631.70
Book Value per Share MRQ CHF41.83

Cash Flow

Operating Cash Flow TTM CHF450,462,016
Levered Free Cash Flow TTM CHF-2,119,343,744

BION Stock Info as of Jan. 3, 2026

Stock Statistics

Shares Outstanding 54,625,250
Float Shares None
Avg 10 Volume 60,141
Avg 30 Volume None
Shares Short None
Short Ratio
Short % of Shares %
% Held by Insiders 0.08%
% Held by Institutions 15.02%

Stock Price Summary

Beta 0.70
Fifty Two Week Low CHF24.35
Fifty Two Week High CHF47.10
Fifty Two Week Change 19.24%
Day 50 MA CHF43.46
Day 200 MA CHF34.72

Dividends and Splits

Forward Annual Dividend Rate CHF7.20
Forward Annual Dividend Yield 16.02%
Trailing Annual Dividend Rate CHF1.80
Trailing Annual Dividend Yield 4.00%
Payout Ratio 59.60%
Dividend Date 2025-03-25
Ex Dividend Date 2025-03-21
Last Split Factor
Last Split Date 2016-03-29